Per Sindahl

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Angiotensin Converting Enzyme

Randomized Controlled Trial

Ejection Fraction

Top Venues

Journal of clinical medicine

British journal of clinical pharmacology

Universiteit Utrecht

University of Copenhagen (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universiteit Utrecht Jan 01 2018

Netherlands

PhD fellow :: Pharmacoepidemiology & Clinical Pharmacology

University of Copenhagen

Denmark

Guest student :: Copenhagen Centre for Regulatory Science

Danish Medicines Agency Feb 01 2010

Denmark

Senior assessor :: Pharmacovigilance

Education History

University of Copenhagen Aug 01 1998 - Aug 20 2003

Denmark

MSC :: School of Pharmaceutical Sciences

Publications

Per Sindahl, Christian Overgaard-Steensen, Helle Wallach-Kildemoes, Marie Louise De Bruin, Kaare Kemp, Helga Gardarsdottir
Impact of a Treatment Guide on Intravenous Fluids in Minimising the Risk of Hospital-Acquired Hyponatraemia in Denmark. Journal of clinical medicine 12 (15) (2023)
Per Sindahl, Richard Ofori-Asenso, Christine Erikstrup Hallgreen, Kaare Kemp, Helga Gardarsdottir, Marie Louise De Bruin
Impact of regulatory interventions to restrict the combined use of renin-angiotensin system blockers: A Danish nationwide drug utilisation study. British journal of clinical pharmacology (2021)
Per Sindahl, Christian Overgaard-Steensen, Helle Wallach-Kildemoes, Marie Louise De Bruin, Hubert Gm Leufkens, Kaare Kemp, Helga Gardarsdottir
Are Further Interventions Needed to Prevent and Manage Hospital-Acquired Hyponatraemia? A Nationwide Cross-Sectional Survey of IV Fluid Prescribing Practices. Journal of clinical medicine 9 (9) (2020)